Turner Joseph L
SEC-identified person · CIK 1266129 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | Director | filed 2020 - 2022 |
| Viridian Therapeutics, Inc.\DE VRDN | Director | filed 2017 - 2021 |
| Alexza Pharmaceuticals Inc. ALXA | Director | filed 2010 - 2016 |
| Kythera Biopharmaceuticals INC KYTH | Director | filed 2012 - 2015 |
| Corcept Therapeutics INC CORT | Director | filed 2010 - 2015 |
| Sophiris BIO INC. SPHS | Director | filed 2013 - 2015 |
| Allos Therapeutics INC ALTH | Director | filed 2012 - 2012 |
| QLT INC/BC QLTI | Director | filed 2010 - 2011 |
| SGX Pharmaceuticals, INC. sgxp | Director | filed 2007 - 2008 |
| Myogen INC MYOG | SVP Fin & Admin, CFO & Treas | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.